GAA-FGF14 ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment response

神经病理学 共济失调 脊髓小脑共济失调 医学 运动障碍 内科学 自然史研究 心理学 疾病 自然史 精神科
作者
Carlo Wilke,David Pellerin,David Mengel,Andreas Traschütz,Matt C. Danzi,Marie‐Josée Dicaire,Manuela Neumann,Holger Lerche,Benjamin Bender,Henry Houlden,Jennifer Faber,Richard Roxburgh,José Luiz Pedroso,Paula Camila Alvez,Orlando Graziani Póvoas Barsottini,Chiara Pane,Francesco Saccà,Henry Houlden,Filippo M. Santorelli,Ivana Ricca,Stephan Züchner,Lüdger Schöls,Bernard Brais,Matthis Synofzik
出处
期刊:Brain [Oxford University Press]
卷期号:146 (10): 4144-4157 被引量:38
标识
DOI:10.1093/brain/awad157
摘要

Abstract Ataxia due to an autosomal dominant intronic GAA repeat expansion in FGF14 [GAA-FGF14 ataxia, spinocerebellar ataxia 27B (SCA27B)] has recently been identified as one of the most common genetic late-onset ataxias. We here aimed to characterize its phenotypic profile, natural history progression, and 4-aminopyridine (4-AP) treatment response. We conducted a multi-modal cohort study of 50 GAA-FGF14 patients, comprising in-depth phenotyping, cross-sectional and longitudinal progression data (up to 7 years), MRI findings, serum neurofilament light (sNfL) levels, neuropathology, and 4-AP treatment response data, including a series of n-of-1 treatment studies. GAA-FGF14 ataxia consistently presented as late-onset [60.0 years (53.5–68.5), median (interquartile range)] pancerebellar syndrome, partly combined with afferent sensory deficits (55%) and dysautonomia (28%). Dysautonomia increased with duration while cognitive impairment remained infrequent, even in advanced stages. Cross-sectional and longitudinal assessments consistently indicated mild progression of ataxia [0.29 Scale for the Assessment and Rating of Ataxia (SARA) points/year], not exceeding a moderate disease severity even in advanced stages (maximum SARA score: 18 points). Functional impairment increased relatively slowly (unilateral mobility aids after 8 years in 50% of patients). Corresponding to slow progression and low extra-cerebellar involvement, sNfL was not increased relative to controls. Concurrent second diseases (including progressive supranuclear palsy neuropathology) represented major individual aggravators of disease severity, constituting important caveats for planning future GAA-FGF14 trials. A treatment response to 4-AP with relevance for everyday living was reported by 86% of treated patients. A series of three prospective n-of-1 treatment experiences with on/off design showed marked reduction in daily symptomatic time and symptom severity on 4-AP. Our study characterizes the phenotypic profile, natural history progression, and 4-AP treatment response of GAA-FGF14 ataxia. It paves the way towards large-scale natural history studies and 4-AP treatment trials in this newly discovered, possibly most frequent, and treatable late-onset ataxia.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
MrQ完成签到,获得积分10
刚刚
刚刚
领导范儿的应助被鹿小飞采纳,获得10
刚刚
CHB只争朝夕完成签到,获得积分10
1秒前
吕峰完成签到,获得积分10
1秒前
认真的平卉完成签到,获得积分10
1秒前
molihuakai的应助被Brilliant采纳,获得10
2秒前
范宇航发布了新的文献求助10
2秒前
仲棠发布了新的文献求助10
2秒前
热心王友发布了新的文献求助10
2秒前
2秒前
2秒前
yalin发布了新的文献求助10
2秒前
安安完成签到 ,获得积分10
3秒前
may完成签到 ,获得积分10
3秒前
3秒前
微风发布了新的文献求助10
4秒前
4秒前
lincsh发布了新的文献求助10
6秒前
wanci的应助被catherine采纳,获得10
6秒前
yjq完成签到,获得积分10
6秒前
Orange的应助被初初初啊采纳,获得10
6秒前
花楹发布了新的文献求助10
6秒前
FashionBoy的应助被CHB只争朝夕采纳,获得10
6秒前
Sylva发布了新的文献求助10
6秒前
Michelle完成签到,获得积分10
6秒前
7秒前
binyh发布了新的文献求助10
7秒前
宇文天思发布了新的文献求助10
7秒前
7秒前
麤七发布了新的文献求助10
8秒前
8秒前
马晓宇发布了新的文献求助10
8秒前
Jasper的应助被111采纳,获得10
8秒前
9秒前
Orange的应助被认真的平卉采纳,获得10
9秒前
wanci的应助被miaomiao采纳,获得10
9秒前
体贴太英发布了新的文献求助10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Monte Cassino in the Middle Ages Volume I 310
JUSTIFICATION OF SMALL-SCALE MODELS: AN INDUSTRY PERSPECTIVE 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8157576
求助须知:如何正确求助?哪些是违规求助? 9553483
关于积分的说明 21714809
捐赠科研通 7746749
什么是DOI,文献DOI怎么找? 3426800
关于科研通互助平台的介绍 2551516
邀请新用户注册赠送积分活动 2470809